Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any mitochondrial complex III deficiency in which the cause of the disease is a mutation in the LYRM7 gene.
Features include always present findings: Global brain atrophy, Generalized hypotonia, Thin corpus callosum, and Low red blood cell count (anemia) and others; and common findings: Elevated brain lactate level by MRS, Nystagmus, Muscle weakness, and Exotropia and others. 41 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 15 | Encephalopathy, Elevated brain lactate level by MRS, Global brain atrophy |
LYRM7 encodes LYR motif containing 7 (104 aa). Assembly factor required for Rieske Fe-S protein UQCRFS1 incorporation into the cytochrome b-c1 (CIII) complex. Highest expression in Cells EBV-transformed lymphocytes (17.7 TPM) and Brain Frontal Cortex BA9 (13.8 TPM).
Mitochondrial complex III deficiency nuclear type 8 is associated with mutations in the LYRM7 gene on chromosome 5.
The LYRM7 protein participates in 2Fe-2S is inserted in UQCRFS1 pathway.
LYRM7 is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for LYRM7 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 19 always present features, 11 common features.
No clinical trials have been registered for mitochondrial complex III deficiency nuclear type 8.
8 publications have been identified in PubMed for mitochondrial complex III deficiency nuclear type 8. Research spans Case Report / Case Series (38%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (25%).
Khan GS (2026). [PMID: 42060169](https://pubmed.ncbi.nlm.nih.gov/42060169/). *J Mol Neurosci*. [Review / Meta-Analysis]
Dewan L (2025). [PMID: 41045959](https://pubmed.ncbi.nlm.nih.gov/41045959/). *Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus*. [Case Report / Case Series]
Luke ND (2025). [PMID: 40317892](https://pubmed.ncbi.nlm.nih.gov/40317892/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Choi RH (2025). [PMID: 40254778](https://pubmed.ncbi.nlm.nih.gov/40254778/). *Obesity (Silver Spring, Md.)*. [Basic Science / Preclinical]
Dong H (2025). [PMID: 39878121](https://pubmed.ncbi.nlm.nih.gov/39878121/). *Autophagy*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 5:19 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles | 8 | Shrinkage of the cerebellum (cerebellar atrophy), Global brain atrophy, Generalized hypotonia |
Lab test results | 4 | Abnormal circulating creatine kinase concentration, Decreased activity of mitochondrial complex III, Increased circulating lactate concentration |
Eyes | 4 | Nystagmus, Ptosis, Visual impairment |
Growth and development | 1 | Failure to thrive |
Blood and immune system | 1 | Low red blood cell count (anemia) |
Lungs and breathing | 1 | Respiratory failure |
Rezaei M (2024). [PMID: 38592654](https://pubmed.ncbi.nlm.nih.gov/38592654/). *Acta neurologica Belgica*. [Case Report / Case Series]
Čunátová K (2024). [PMID: 39053894](https://pubmed.ncbi.nlm.nih.gov/39053894/). *Journal of inherited metabolic disease*. [Review / Meta-Analysis]
Rouzier C (2024). [PMID: 38703036](https://pubmed.ncbi.nlm.nih.gov/38703036/). *Annals of clinical and translational neurology*. [Epidemiology / Natural History]